Assessing Velazidone's Efficacy in Depression and Anxiety Disorders

The chapter examines the effectiveness of Velazidone in managing depression and anxiety disorders, emphasizing its shortcomings in treating treatment-resistant depression and the lack of convincing long-term data. It dispels the belief that new drugs are inherently better for anxiety treatment, explaining that Velazidone's similarities to existing medications do not guarantee efficacy, given its lack of FDA approval and underwhelming trial outcomes.